Editas Medicine (EDIT) Revenue (2015 - 2025)
Editas Medicine's Revenue was $7.54 million in Q3 2025, compared with $61,000 a year earlier and up 110.8% from the prior quarter.
Powered by 
Analysis
Editas Medicine (EDIT) Revenue (2015 - 2025) Analysis & Trends
On a trailing twelve-month basis, Editas Medicine's Revenue was $46.38 million through Sep 30, 2025, down 24.9% year-over-year; for FY2024, it was $32.31 million, down 58.6% from FY2023.
- Revenue shows a five-year compound annual growth rate of 9.5% (FY2019 to FY2024).
- In earlier years, Revenue was $78.12 million in FY2023 (+296.3%), $19.71 million in FY2022 (-22.8%), $25.54 million in FY2021 (-71.8%) and $90.73 million in FY2020 (+341.9%).
- Quarterly Revenue has moved between $42,000 (Q3 2022) and $60.05 million (Q4 2023) over five years.
- Compared with a year earlier, Revenue was higher in three of the last seven quarters, with growth averaging 201.1%.
- The best year-over-year quarter for Revenue over five years was Q4 2023 (growth of 818.7%); the worst was Q3 2022 (a decline of 99.3%).
- Per Business Quant data, EDIT's Revenue in the three quarters before Q3 2025 was $3.58 million (Q2 2025), $4.66 million (Q1 2025) and $30.6 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Editas Medicine | 235.03 Mn | -476.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Mar 31, 2025 | 4.66 Mn |
| Dec 31, 2024 | 30.60 Mn |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 513,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 60.05 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 2.89 Mn |
| Mar 31, 2023 | 9.85 Mn |
| Dec 31, 2022 | 6.54 Mn |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 6.36 Mn |
| Mar 31, 2022 | 6.77 Mn |
| Dec 31, 2021 | 12.47 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Jun 30, 2021 | 379,000.00 |
| Mar 31, 2021 | 6.50 Mn |
| Dec 31, 2020 | 11.42 Mn |
API Access
Editas Medicine Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "EDIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=EDIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();